News & Media Press releases & statements Month Year Su Mo Tu We Th Fr Sa 25 26 27 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 2 3 4 5 Cancel Apply filter Month Year Su Mo Tu We Th Fr Sa 25 26 27 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 2 3 4 5 Cancel Apply filter Year All Years 2023 2022 2021 2020 2019 2018 2017 2016 2015 Category All categories Type - Statement - Press release Topic - Corporate and finance - Global health - Partnerships Research area - COVID-19 - Ebola - RSV - Seasonal influenza Uncategorized Keywords Apply filter Advanced Search Search Search Headlines Only Type All Statement Press release Topic All Corporate and finance Global health Partnerships Research area All COVID-19 Ebola RSV Seasonal influenza From To Asset Types Photos Video Audio Documents Events Standard Nov 17, 2021 COVID-19 Novavax Confirms European Medicines Agency Review of COVID-19 Vaccine Filing for Conditional Marketing Authorization Download Nov 17, 2021 Corporate and financeCOVID-19 Novavax and Serum Institute of India Receive Emergency Use Authorization for COVID-19 Vaccine in the Philippines Download Nov 15, 2021 Novavax Announces Submission of Biologics License Application in South Korea for Approval of NVX-CoV2373 Download Nov 10, 2021 StatementCOVID-19 Novavax Statement on UK and Mexico Phase 3 Clinical Trial Participants Considered Fully Vaccinated in the US Download Nov 4, 2021 Corporate and finance Novavax Reports Third Quarter 2021 Financial Results and Operational Highlights Download Nov 4, 2021 Corporate and financeCOVID-19 Novavax Files COVID-19 Vaccine for Emergency Use Listing with World Health Organization Download Nov 3, 2021 COVID-19 Novavax Files COVID-19 Vaccine for Provisional Approval in New Zealand Download Nov 1, 2021 COVID-19 Novavax and Serum Institute of India Receive Emergency Use Authorization for COVID-19 Vaccine in Indonesia Download Nov 1, 2021 Corporate and financeCOVID-19 Novavax Files for COVID-19 Vaccine Authorization with Health Canada and Completes Submission for Rolling Review to European Medicines Agency Download Oct 29, 2021 Corporate and financeCOVID-19 Novavax Files for Provisional Approval of its COVID-19 Vaccine in Australia Download Oct 27, 2021 Corporate and financeCOVID-19 Novavax Files for Authorization of its COVID-19 Vaccine in the United Kingdom Download Oct 20, 2021 StatementCOVID-19 Novavax Reconfirms Confidence in Regulatory Filing Timelines and Manufacturing Quality Download Oct 19, 2021 StatementCOVID-19 Novavax Statement on Initial Com-COV2 Phase 2 Clinical Trial Results Presented at World Vaccine Congress Europe Download Oct 18, 2021 Corporate and finance Novavax to Host Conference Call to Discuss Third Quarter Financial Results and Operational Highlights on November 4, 2021 Download Oct 15, 2021 COVID-19Seasonal influenza Novavax to Participate in World Vaccine Congress Europe Download Oct 11, 2021 StatementCOVID-19 Complete PREVENT-19 Phase 3 Clinical Trial Results Manuscript for COVID-19 Vaccine Posted to medRxiv Download Oct 4, 2021 Corporate and finance Novavax Announces Leadership Appointment and Updates Download Sep 29, 2021 COVID-19 Novavax to Participate in Health Equity and Vaccine Confidence Panel at Maryland Life Sciences Bio Innovation Conference Download Sep 24, 2021 COVID-19 Novavax Hosts HM King Carl XVI Gustaf and HM Queen Silvia of Sweden During Royal Visit to Uppsala County Download Sep 23, 2021 Seasonal influenza Results from Novavax NanoFlu Influenza Vaccine Phase 3 Clinical Trial Published in The Lancet Infectious Diseases Download Sep 23, 2021 COVID-19 Novavax and Serum Institute of India Announce Submission to World Health Organization for Emergency Use Listing of Novavax' COVID-19 Vaccine Download Sep 23, 2021 Corporate and finance Novavax to Participate in Fireside Chat at the 2021 Cantor Virtual Global Healthcare Conference Download Sep 20, 2021 COVID-19 Novavax to Participate in Fireside Chat at Devex @ UNGA 76 Download Sep 17, 2021 StatementCOVID-19 Novavax Statement on Proof of COVID-19 Vaccine Requirements for PREVENT-19 Clinical Trial Participants in the U.S. Download Sep 16, 2021 COVID-19 Novavax to Participate in University of Oxford Com-COV3 Study Comparing Mixed COVID-19 Vaccine Schedule in Adolescents Download Sep 10, 2021 StatementCOVID-19 Novavax Statement on Takeda Agreement to Provide 150 Million Doses of NVX-CoV2373 to the Government of Japan Download Sep 9, 2021 Corporate and finance Novavax to Participate in Upcoming September Conferences Download Sep 8, 2021 COVID-19 Novavax Initiates Phase 1/2 Clinical Trial of Combination Vaccine for COVID-19 and Seasonal Influenza Download Sep 7, 2021 Corporate and finance Novavax to Participate in Citi's 16th Annual BioPharma Virtual Conference 2021 Download Aug 30, 2021 COVID-19 Novavax Statement on CDC Guidance Update for COVID-19 Clinical Trial Participants Download Aug 25, 2021 COVID-19 Novavax to Participate in OCTAVE-DUO Study to Evaluate Third Dose of Vaccine in Participants with Impaired Immune Systems Download Aug 16, 2021 Corporate and finance Novavax Appoints Biopharmaceutical Veterans Jim Kelly as Chief Financial Officer and Nasir Egal, Ph.D., as Senior Vice President of Quality Assurance Download Aug 5, 2021 Novavax Reports Second Quarter 2021 Financial Results and Operational Highlights Download Aug 5, 2021 COVID-19 Novavax Announces COVID-19 Vaccine Booster Data Demonstrating Four-Fold Increase in Neutralizing Antibody Levels Versus Peak Responses After Primary Vaccination Download Aug 5, 2021 COVID-19 Novavax and Serum Institute of India Announce Submission to Regulatory Agencies in India, Indonesia, Philippines for Emergency Use Authorization of Novavax' Recombinant Nanoparticle COVID-19 Vaccine Download Aug 4, 2021 COVID-19 Novavax and European Commission Finalize Advance Purchase Agreement for up to 200 million doses of COVID-19 Vaccine Download Jul 6, 2021 Corporate and finance Novavax to Host Conference Call to Discuss Second Quarter Financial Results and Operational Highlights on August 5, 2021 Download Jun 30, 2021 COVID-19 Novavax Publishes Results of United Kingdom Phase 3 Clinical Trial in New England Journal of Medicine, Demonstrating High Levels of Efficacy of COVID-19 Vaccine Download Jun 30, 2021 StatementCOVID-19 Novavax Statement on Proof of Vaccination for Phase 3 Clinical Trial Participants: Updated June 30, 2021 Download Jun 22, 2021 StatementCOVID-19 Novavax Statement on Completion of the National Research Council of Canada Biologics Manufacturing Centre Download Jun 17, 2021 Corporate and finance Novavax to Participate in Fireside Chat at SVB Leerink CybeRx Series: Vaccine Forum Download Jun 17, 2021 Corporate and finance Novavax to Participate in National Vaccine Advisory Committee Meeting Download Jun 14, 2021 COVID-19Seasonal influenza Novavax Announces Positive Results from First Study of Influenza Vaccine and COVID-19 Vaccine Candidate Administered Simultaneously Download Jun 14, 2021 COVID-19 Novavax COVID-19 Vaccine Demonstrates 90% Overall Efficacy and 100% Protection Against Moderate and Severe Disease in PREVENT-19 Phase 3 Trial Download Jun 11, 2021 COVID-19 Novavax Announces Positive Data from Three Complementary Studies of COVID-19 Beta (B.1.351) Variant Strain Vaccine Download Jun 9, 2021 Corporate and finance Novavax to Host Maryland Governor Larry Hogan at Site of Future Novavax Vaccines Innovation Campus and Global Headquarters Download Jun 7, 2021 COVID-19 Novavax to Participate in Panel at BIO Digital 2021 Download May 27, 2021 COVID-19 Novavax to Participate in Jefferies Virtual Healthcare Conference Download May 24, 2021 COVID-19 Novavax to Present at International Society for Vaccines Virtual Congress COVID-19 Vaccine Update Download May 22, 2021 COVID-19 Novavax Announces Memorandum of Understanding to Explore Expansion of COVID-19 Vaccine Activities in South Korea Download Show 5102550100 per page«123456789»